Animal & Veterinary
Supplemental New Animal Drug Approvals - January/February 2002
FDA Veterinarian Newsletter January/February 2002 Volume XVII, No 1
|Company||Generic and (Brand) Names||Indications||Routes/Remarks|
|Schering-Plough Animal Health Corp.|
|Turkeys. For prevention of coccidiosis.|
MEDICATED FEED—The supplemental NADA provides for use of the approved diclazuril Type A medicated article to make Type B and Type C medicated turkey feeds used for prevention of coccidiosis caused by Eimeria adenoeides, E. gallopavonis, and E. melagrimitis. Also, the NADA establishes tolerances for diclazuril residues in turkey liver at 3 ppm, muscle at 0.5 ppm, and skin with adherent fat at 1 ppm.
Federal Register 12/04/01
(Rimadyl® Caplets) Rx
|Dogs. For the relief of pain and inflammation associated with osteoarthritis.|
ORAL—The supplement provides for a once daily, 2 mg/lb dosage of carprofen, by oral caplet.
Federal Register 12/05/01
(MoorMan's Mintrate Blonde Block RU and MoorMan's Mintrate Red Block RU)
|Cattle. For prevention and control of coccidiosis.|
MEDICATED FEED—The supplement provides for use of approved monensin Type A medicated
articles to make free-choice, medicated feed blocks used for prevention and control of coccidiosis
caused by Eimeria bovis and E. zuernii in pasture cattle.
Federal Register 12/07/01